Alpine Immune Sciences Inc
ALPN
ALPN was delisted on the 17th of May, 2024.
21 hedge funds and large institutions have $34.4M invested in Alpine Immune Sciences Inc in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 5 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
6% less capital invested
Capital invested by funds: $36.7M → $34.4M (-$2.31M)
13% less funds holding
Funds holding: 24 → 21 (-3)
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HP
Hikari Power
Tokyo,
Japan
|
+$276K |
| 2 |
Renaissance Technologies
New York
|
+$26.2K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$10.7K |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$6.79K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$1.51K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$90K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$66.7K |
| 3 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$66K |
| 4 |
BI
BVF Inc
San Francisco,
California
|
-$59.9K |
| 5 |
DM
Deerfield Management
New York
|
-$38.5K |
ALPN Hedge Fund Activity: Q3 2019 in Review
21 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Alpine Immune Sciences Inc (ALPN) for Q3 2019, worth a combined $34.4M — down 6.3% from $36.7M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of ALPN and 2 opened new positions — a net loss of 3 holders — while 6 trimmed existing stakes and 6 added.
The largest buyer was Hikari Power, adding an estimated $276K. The largest seller was Jacobs Levy Equity Management, exiting entirely with an estimated $90K sold.
- 21 institutional investors held Alpine Immune Sciences Inc (ALPN) as of Q3 2019, down from 24 in Q2 2019.
- Funds reported $34.4M of Alpine Immune Sciences Inc stock for Q3 2019, down 6.3% quarter-over-quarter.
- 2 funds opened new Alpine Immune Sciences Inc positions in Q3 2019 and 5 closed out, a net change of -3 holders.
- The largest Alpine Immune Sciences Inc buyer in Q3 2019 was Hikari Power, an estimated $276K added.
- The largest Alpine Immune Sciences Inc seller in Q3 2019 was Jacobs Levy Equity Management, an estimated $90K sold.
Based on aggregated 13F filings for Q3 2019.